✦ LIBER ✦

421 A Phase Ib study to evaluate the pan-PI3K inhibitor GDC-0941 with paclitaxel and carboplatin with and without bevacizumab in non-small cell lung cancer patients

✍ Scribed by J.C. Soria; C.A. Gomez-Roca; J.A. Ware; A.A. Adjei; R.K. Brachmann; H.J.M. Groen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9012 POSTER DISCUSSION A Phase lb Study

✍ Groen, H.; Adjei, A.A.; Dy, G.K.; Ware, J.A.; Shankar, G.; Brachmann, R.K.; Bess 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A phase III randomized study of carbopla

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

A phase I pharmacokinetic study of bexar

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Phase II trial of ixabepilone and carbop

✍ Spigel, David R.; Anthony Greco, F.; Waterhouse, David M.; Shipley, Dianna L.; Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Phase I and pharmacokinetic study of car

✍ M. Ichiki; R. Gohara; R. Fujiki; S. Hoashi; T. Rikimaru; H. Aizawa 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

A phase II study of weekly paclitaxel an

✍ Andre Michel Kallab; Yasolatha Nalamolu; Paul Maclyn Dainer; Anand Prasad Jillel 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 73 KB